The current valuation score of X4 Pharmaceuticals Inc is 7.33, ranking 111 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -1.21, which is -16260.17% below the recent high of 195.65 and -26017.06% above the recent low of -316.20.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.